注:本產品僅用于科研,不可用于臨床
| 生物活性 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IC50 & Target |
| ||||||||||||||||
| 體外研究 (In Vitro) | ATP (5 mM; 1 hour) co-treatment with LPS (1 μg/mL) has a synergistic effect on the activation of the NLRP3 inflammasome in HGFs[3]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
| 體內研究 (In Vivo) | ATP (50 mg/kg; i.p.) protects mice against bacterial infection in vivo[4]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
| 分子量 | 507.18 | ||||||||||||||||
| 性狀 | Solid | ||||||||||||||||
| Formula | C10H16N5O13P3 | ||||||||||||||||
| CAS 號 | 56-65-5 | ||||||||||||||||
| 中文名稱 | 腺苷三磷酸 | ||||||||||||||||
| 結構分類 |
| ||||||||||||||||
| 來源 |
widespread | ||||||||||||||||
| 運輸條件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 儲存方式 |
| ||||||||||||||||
| 溶解性數據 | In Vitro: H2O : ≥ 100 mg/mL (197.17 mM) * "≥" means soluble, but saturation unknown. 配制儲備液
* 請根據產品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液;一旦配成溶液,請分裝保存,避免反復凍融造成的產品失效。 In Vivo: 請根據您的實驗動物和給藥方式選擇適當的溶解方案。以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液,再依次添加助溶劑: ——為保證實驗結果的可靠性,澄清的儲備液可以根據儲存條件,適當保存;體內實驗的工作液,建議您現用現配,當天使用; 以下溶劑前顯示的百
|







采購中心
